ClinConnect ClinConnect Logo
Search / Trial NCT06513377

Evaluating and Monitoring Physical Fatigue While Performing Functional Activities

Launched by VRIJE UNIVERSITEIT BRUSSEL · Jul 16, 2024

Trial Information

Current as of August 20, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Stroke survivors:
  • Inclusion Criteria:
  • \> 18 years old
  • ≥ 3 months ago stroke diagnosis
  • FAC levels 3-5
  • Exclusion Criteria:
  • Severe problems with speech or memory which prevents the participant to understand or follow instruction
  • Co-morbidities that could influence the task execution and collected data
  • Older adults with sarcopenia:
  • Inclusion:
  • \> 65 years old
  • Grip strength: \< 27 kg (man) or \< 16 kg (woman)
  • Be mobile independently
  • Exclusion:
  • Severe problems with speech or memory which prevents the participant to understand or follow instruction
  • Co-morbidities that could influence the task execution and collected data
  • Healthy individuals:
  • Inclusion:
  • \> 18 years old
  • Healthy physical and medical condition
  • Exclusion:
  • Physical injury or disorder that doesn't allow good physical performance

About Vrije Universiteit Brussel

The Vrije Universiteit Brussel (VUB) is a distinguished research university located in Brussels, Belgium, known for its commitment to innovative education and cutting-edge research across various disciplines. As a clinical trial sponsor, VUB actively engages in advancing medical knowledge and improving patient care through rigorous scientific investigations. The university fosters collaborations with healthcare institutions and industry partners, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements. VUB's research initiatives are driven by a multidisciplinary approach, leveraging expertise from fields such as medicine, health sciences, and biomedical engineering to address pressing health challenges and contribute to the development of novel therapies.

Locations

Jette, Brussels, Belgium

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported